Company intelligence

iSpecimen

BiotechWoburn, Massachusetts, USA

Recent changes

  1. Jun 24, 2026Biospecimen Marketplace iSpecimen Files a Form S-1 With the SEC Pulse story
  2. May 11, 2026Raised $2.5M SEC EDGAR Form D

Funding History

1 event · sources dated per row
DateEventAmountValuationInvestorsSource
May 11, 2026funding round$2.5M—
SEC EDGAR Form D

Latest Pulse

  1. 12 New S-1 Filings Show a Micro-Cap Biotech WaveA dozen new SEC S-1 and S-1/A filings this week, dominated by small biotech and biopharma names, show a steady drip of micro-cap public offerings continuing well below the AI-mega-cap headlines dominating the IPO conversation.→
  2. Seven Companies File S-1s in a Single WeekSeven companies spanning biotech, fintech, AI and battery materials filed IPO registration paperwork with the SEC within days of each other, a broad-based cluster that extends the sustained widening of 2026's listing pipeline.→
  3. Biospecimen Marketplace iSpecimen Files a Form S-1 With the SECiSpecimen, which operates an online marketplace connecting medical researchers with human biological specimens, filed a Form S-1 with the SEC. The filing adds a health-data and life-sciences infrastructure name to a 2026 IPO pipeline that has skewed heavily toward AI labs and semiconductors.→

Coverage Timeline

newest first
  1. Jun 24, 2026IPOBiospecimen Marketplace iSpecimen Files a Form S-1 With the SECS-1 filed→

All Coverage

Related Companies

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction